These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39153074)

  • 21. A patient with Silver-Russell syndrome with multilocus imprinting disturbance, and Schimke immuno-osseous dysplasia unmasked by uniparental isodisomy of chromosome 2.
    Hara-Isono K; Matsubara K; Hamada R; Shimada S; Yamaguchi T; Wakui K; Miyazaki O; Muroya K; Kurosawa K; Fukami M; Ogata T; Kosho T; Kagami M
    J Hum Genet; 2021 Nov; 66(11):1121-1126. PubMed ID: 34031513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression.
    Baradaran-Heravi A; Cho KS; Tolhuis B; Sanyal M; Morozova O; Morimoto M; Elizondo LI; Bridgewater D; Lubieniecka J; Beirnes K; Myung C; Leung D; Fam HK; Choi K; Huang Y; Dionis KY; Zonana J; Keller K; Stenzel P; Mayfield C; Lücke T; Bokenkamp A; Marra MA; van Lohuizen M; Lewis DB; Shaw C; Boerkoel CF
    Hum Mol Genet; 2012 Jun; 21(11):2572-87. PubMed ID: 22378147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dental abnormalities in Schimke immuno-osseous dysplasia.
    Morimoto M; Kérourédan O; Gendronneau M; Shuen C; Baradaran-Heravi A; Asakura Y; Basiratnia M; Bogdanovic R; Bonneau D; Buck A; Charrow J; Cochat P; Dehaai KA; Fenkçi MS; Frange P; Fründ S; Fryssira H; Keller K; Kirmani S; Kobelka C; Kohler K; Lewis DB; Massella L; McLeod DR; Milford DV; Nobili F; Olney AH; Semerci CN; Stajic N; Stein A; Taque S; Zonana J; Lücke T; Hendson G; Bonnaure-Mallet M; Boerkoel CF
    J Dent Res; 2012 Jul; 91(7 Suppl):29S-37S. PubMed ID: 22699664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schimke immunoosseous dysplasia and management considerations for vascular risks.
    Beleford DT; Diab M; Qubty WF; Malloy MJ; Long RK; Shieh JT
    Am J Med Genet A; 2019 Jul; 179(7):1246-1252. PubMed ID: 31039288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different Phenotypes of Schimke Immuno-Osseous Dysplasia (SIOD) in Two Sisters with the Same Mutation in the SMARCAL1 Gene.
    Castellano-Martinez A; Acuñas-Soto S; Varga-Martinez R; Rodriguez-Gonzalez M; Mora-Lopez F; Iriarte-Gahete M; Roldan-Cano V
    Endocr Metab Immune Disord Drug Targets; 2022; 22(8):888-894. PubMed ID: 35209826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Schimke immuno-osseous dysplasia. A pediatric disease reaches adulthood].
    Lücke T; Kanzelmeyer N; Franke D; Hartmann H; Ehrich JH; Das AM
    Med Klin (Munich); 2006 Mar; 101(3):208-11. PubMed ID: 16648978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dental abnormalities and preventive oral care in Schimke immuno-osseous dysplasia.
    Gendronneau M; Kérourédan O; Taque S; Sixou JL; Bonnaure-Mallet M
    Eur Arch Paediatr Dent; 2014 Jun; 15(3):217-21. PubMed ID: 24327104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-induced conformation changes drive ATP hydrolysis and function in SMARCAL1.
    Gupta M; Mazumder M; Dhatchinamoorthy K; Nongkhlaw M; Haokip DT; Gourinath S; Komath SS; Muthuswami R
    FEBS J; 2015 Oct; 282(19):3841-59. PubMed ID: 26195148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel SMARCAL1 missense mutation that affects splicing in a severely affected Schimke immunoosseous dysplasia patient.
    Barraza-García J; Rivera-Pedroza CI; Belinchón A; Fernández-Camblor C; Valenciano-Fuente B; Lapunzina P; Heath KE
    Eur J Med Genet; 2016 Aug; 59(8):363-6. PubMed ID: 27282802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eltrombopag (thrombopoietin-receptor agonist) and plasmapheresis as rescue therapy of acute post-renal transplant immune thrombocytopenia in a child with Schimke immuno-osseous dysplasia-case report.
    Grenda R; Jarmużek W; Latoszyńska J; Prokurat S; Rubik J
    Pediatr Transplant; 2016 Dec; 20(8):1148-1151. PubMed ID: 27671102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent.
    Marin AV; Jiménez-Reinoso A; Mazariegos MS; Román-Ortiz E; Regueiro JR
    Front Immunol; 2022; 13():979722. PubMed ID: 36330520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional and posttranscriptional mechanisms contribute to the dysregulation of elastogenesis in Schimke immuno-osseous dysplasia.
    Morimoto M; Wang KJ; Yu Z; Gormley AK; Parham D; Bogdanovic R; Lücke T; Mayfield C; Weksberg R; Hendson G; Boerkoel CF
    Pediatr Res; 2015 Dec; 78(6):609-17. PubMed ID: 26309238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.
    Bertaina A; Grimm PC; Weinberg K; Parkman R; Kristovich KM; Barbarito G; Lippner E; Dhamdhere G; Ramachandran V; Spatz JM; Fathallah-Shaykh S; Atkinson TP; Al-Uzri A; Aubert G; van der Elst K; Green SG; Agarwal R; Slepicka PF; Shah AJ; Roncarolo MG; Gallo A; Concepcion W; Lewis DB
    N Engl J Med; 2022 Jun; 386(24):2295-2302. PubMed ID: 35704481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schimke immune-osseous dysplasia: A case report.
    Bakr A; Eid R; Sarhan A; Hammad A; El-Refaey AM; El-Mougy A; Zedan MM; ElHusseini F
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):987-91. PubMed ID: 26354575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated multiplex ligation dependent probe amplification (MLPA) assays for the detection of alterations in the HEXB, GM2A and SMARCAL1 genes to support the diagnosis of Morbus Sandhoff, M. Tay-Sachs variant AB and Schimke immuno-osseous dysplasia in humans.
    Sobek AK; Evers C; Dekomien G
    Mol Cell Probes; 2013 Feb; 27(1):32-7. PubMed ID: 23010210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schimke versus non-Schimke chronic kidney disease: an anthropometric approach.
    Lücke T; Franke D; Clewing JM; Boerkoel CF; Ehrich JH; Das AM; Zivicnjak M
    Pediatrics; 2006 Aug; 118(2):e400-7. PubMed ID: 16816006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel compound heterozygous variant in
    Wang L; Li J; Wu G; Kong X
    J Int Med Res; 2021 Apr; 49(4):3000605211010644. PubMed ID: 33900868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia.
    Bökenkamp A; deJong M; van Wijk JA; Block D; van Hagen JM; Ludwig M
    Pediatr Nephrol; 2005 Dec; 20(12):1724-8. PubMed ID: 16237566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMARCAL1, the annealing helicase and the transcriptional co-regulator.
    Bansal R; Hussain S; Chanana UB; Bisht D; Goel I; Muthuswami R
    IUBMB Life; 2020 Oct; 72(10):2080-2096. PubMed ID: 32754981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia.
    Boerkoel CF; Takashima H; John J; Yan J; Stankiewicz P; Rosenbarker L; André JL; Bogdanovic R; Burguet A; Cockfield S; Cordeiro I; Fründ S; Illies F; Joseph M; Kaitila I; Lama G; Loirat C; McLeod DR; Milford DV; Petty EM; Rodrigo F; Saraiva JM; Schmidt B; Smith GC; Spranger J; Stein A; Thiele H; Tizard J; Weksberg R; Lupski JR; Stockton DW
    Nat Genet; 2002 Feb; 30(2):215-20. PubMed ID: 11799392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.